Literature DB >> 16378882

Does this patient have cancer? The assessment of age, anemia, and erythrocyte sedimentation rate in cancer as a cause of weight loss. A retrospective study based on a secondary care university hospital in Romania.

Cristian Baicus1, Razvan Ionescu, Coman Tanasescu.   

Abstract

BACKGROUND: "Does this patient have cancer?" is a question frequently asked when confronted by patients with involuntary weight loss. The aim of this study was to assess the value of age, erythrocyte sedimentation rate (ESR), and anemia in the diagnosis of cancer as a cause of involuntary weight loss.
METHODS: A retrospective study of 7850 patients admitted to the Department of Internal Medicine from January to September 2003 was performed. Especially selected were 431 patients with weight loss. Age, ESR, hemoglobin, and the discharge diagnosis were recorded.
RESULTS: Twenty-four percent of the patients with involuntary weight loss had cancer. Age, ESR, and anemia were found not to be of value in the diagnosis of cancer (areas under the curve were 0.684, 0.690, and 0.766, respectively). When diagnostic tests for age, a high ESR, and anemia were used serially, the positive predictive value for a malignancy was 64% (CI: 27-90%); when the tests were utilized in parallel, the negative predictive value was 91% (CI: 85-100%).
CONCLUSIONS: Any patient admitted to our Department of Internal Medicine for involuntary weight loss had a 24% probability of having a malignancy. Neither age, nor ESR, nor anemia, used separately as a multilevel, diagnostic test or combined serially or in parallel, could exclude or rule in the diagnosis of cancer. However, they could increase (from 24% to 64%) or decrease (from 24% to 9%) the probability of cancer.

Entities:  

Year:  2006        PMID: 16378882     DOI: 10.1016/j.ejim.2005.07.009

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

2.  Ferritin above 100 mcg/L could rule out colon cancer, but not gastric or rectal cancer in patients with involuntary weight loss.

Authors:  Cristian Baicus; Simona Caraiola; Mihai Rimbas; Ruxandra Patrascu; Anda Baicus
Journal:  BMC Gastroenterol       Date:  2012-07-09       Impact factor: 3.067

3.  Cancer and involuntary weight loss: failure to validate a prediction score.

Authors:  Cristian Baicus; Mihai Rimbas; Anda Baicus; Simona Caraiola
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

4.  Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients.

Authors:  Xavier Bosch; Esther Monclús; Ona Escoda; Mar Guerra-García; Pedro Moreno; Neus Guasch; Alfons López-Soto
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

5.  Weight loss might be an early clinical manifestation of undiagnosed cancer: a nation-based cohort study.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2018-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.